Study on Clostridium Difficile Infection in Infants

Launched by FIRST PEOPLE'S HOSPITAL OF HANGZHOU · Nov 21, 2024

Keywords

ClinConnect Summary

This clinical trial is studying Clostridium difficile infection, a type of bacteria that can cause serious gastrointestinal problems, in infants aged 0 to 2 years. Researchers want to understand more about the characteristics of this infection and identify certain markers in the body that could help doctors diagnose and treat it better. They will look at past medical records and gather information from parents through questionnaires to find out what factors might put some infants at higher risk for this infection.

To participate in this study, infants must be between 0 and 2 years old and have confirmed cases of Clostridium difficile infection, or be healthy infants without the infection for comparison. Unfortunately, infants older than 2 years or those with incomplete medical records or other severe gastrointestinal issues cannot take part. If you choose to join, you can expect to help researchers gather important information that could lead to better care for infants with this infection in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Infants ( aged 0-2 years). Medical records and patient questionnaires available with confirmed Clostridium difficile infection (for case group) or without infection (for control group).
• Exclusion Criteria:
• • Infants beyond the age of 2 years at the time of diagnosis. Incomplete medical records or missing essential information related to infection status, feeding methods, or antibiotic exposure.Patients with other severe gastrointestinal conditions that may confound results.